| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
22,714 |
20,548 |
$943K |
| 87636 |
Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B |
5,866 |
5,343 |
$623K |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
8,841 |
7,836 |
$547K |
| 99282 |
Emergency department visit for the evaluation and management, low to moderate severity |
4,103 |
3,816 |
$489K |
| 80048 |
Basic metabolic panel (calcium, ionized) |
10,483 |
9,125 |
$455K |
| 80053 |
Comprehensive metabolic panel |
10,938 |
9,621 |
$436K |
| 81003 |
|
9,460 |
8,598 |
$299K |
| 96360 |
Intravenous infusion, hydration; initial, 31 minutes to 1 hour |
1,624 |
1,495 |
$234K |
| 0241U |
Neonatal screening for hereditary disorders, genomic sequence analysis panel |
1,912 |
1,772 |
$227K |
| 36415 |
Collection of venous blood by venipuncture |
3,490 |
3,020 |
$205K |
| 81025 |
|
8,380 |
7,606 |
$185K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
4,051 |
3,469 |
$179K |
| 81001 |
|
6,446 |
5,838 |
$174K |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
1,517 |
1,452 |
$155K |
| 99284 |
Emergency department visit for the evaluation and management, high severity |
16,573 |
14,866 |
$140K |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
3,955 |
3,630 |
$117K |
| 87210 |
|
1,652 |
1,332 |
$116K |
| 74177 |
Computed tomography, abdomen and pelvis; with contrast material |
3,564 |
3,293 |
$100K |
| 97110 |
Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion |
2,850 |
522 |
$86K |
| 86901 |
|
1,692 |
1,518 |
$84K |
| 84132 |
|
707 |
643 |
$75K |
| 87430 |
|
1,788 |
1,655 |
$72K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
2,078 |
1,980 |
$70K |
| J3490 |
Unclassified drugs |
640 |
474 |
$68K |
| 70450 |
Computed tomography, head or brain; without contrast material |
2,675 |
2,464 |
$63K |
| J7050 |
Infusion, normal saline solution, 250 cc |
392 |
339 |
$61K |
| 80307 |
Drug test(s), presumptive, any number of drug classes; immunoassay |
1,536 |
1,370 |
$60K |
| 93306 |
Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete |
482 |
476 |
$55K |
| 71046 |
Radiologic examination, chest; 2 views |
2,649 |
2,420 |
$53K |
| 84702 |
|
1,752 |
1,416 |
$50K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
1,268 |
1,212 |
$50K |
| 73630 |
|
705 |
652 |
$48K |
| 96361 |
Intravenous infusion, hydration; each additional hour |
4,727 |
4,047 |
$47K |
| 99285 |
Emergency department visit for the evaluation and management, high severity with immediate threat to life |
9,122 |
8,272 |
$43K |
| 71045 |
Radiologic examination, chest; single view |
6,075 |
5,539 |
$40K |
| 96365 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour |
2,434 |
2,223 |
$40K |
| 87040 |
|
2,630 |
1,944 |
$38K |
| 73130 |
|
385 |
345 |
$36K |
| 73562 |
|
658 |
592 |
$31K |
| 84484 |
|
5,803 |
4,497 |
$30K |
| 73610 |
|
387 |
356 |
$27K |
| 93971 |
|
393 |
377 |
$26K |
| 71275 |
Computed tomographic angiography, chest, with contrast material |
1,188 |
1,110 |
$25K |
| 74176 |
Computed tomography, abdomen and pelvis; without contrast material |
1,195 |
1,123 |
$23K |
| J7120 |
Ringers lactate infusion, up to 1000 cc |
517 |
485 |
$20K |
| 77063 |
Screening digital breast tomosynthesis, bilateral |
463 |
455 |
$20K |
| 73030 |
|
354 |
321 |
$19K |
| 85027 |
|
3,451 |
2,960 |
$17K |
| 76817 |
Ultrasound, pregnant uterus, real time with image documentation, transvaginal |
1,381 |
1,153 |
$17K |
| 87428 |
|
117 |
115 |
$14K |
| 99281 |
Emergency department visit for the evaluation and management, self-limited or minor |
239 |
231 |
$14K |
| 73721 |
Magnetic resonance imaging, any joint of lower extremity; without contrast material |
24 |
24 |
$14K |
| 71250 |
|
127 |
120 |
$14K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
1,015 |
417 |
$14K |
| 72148 |
Magnetic resonance imaging, lumbar spine; without contrast material |
67 |
64 |
$13K |
| 76705 |
Ultrasound, abdominal, real time with image documentation; limited |
562 |
537 |
$13K |
| 59025 |
Fetal non-stress test |
295 |
263 |
$12K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
18,685 |
16,094 |
$12K |
| 77067 |
Screening mammography, bilateral, including computer-aided detection |
526 |
515 |
$11K |
| 87633 |
Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets |
97 |
91 |
$11K |
| 88305 |
Level IV - Surgical pathology, gross and microscopic examination |
315 |
275 |
$11K |
| 73110 |
|
169 |
158 |
$11K |
| 80076 |
|
2,170 |
2,001 |
$11K |
| 76830 |
Ultrasound, transvaginal |
482 |
446 |
$10K |
| J7040 |
Infusion, normal saline solution, sterile (500 ml = 1 unit) |
57 |
43 |
$9K |
| G0378 |
Hospital observation service, per hour |
1,632 |
1,051 |
$9K |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
9,022 |
7,861 |
$8K |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
1,801 |
1,660 |
$7K |
| 72141 |
|
27 |
25 |
$7K |
| 96375 |
Therapeutic injection; each additional sequential IV push |
6,052 |
5,196 |
$7K |
| 97530 |
Therapeutic activities, direct patient contact, each 15 minutes |
318 |
70 |
$6K |
| 96366 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour |
328 |
252 |
$6K |
| 84443 |
Thyroid stimulating hormone (TSH) |
1,778 |
1,680 |
$6K |
| 86900 |
|
1,689 |
1,516 |
$6K |
| 96376 |
|
1,501 |
1,173 |
$5K |
| 72100 |
|
180 |
172 |
$4K |
| 72125 |
Computed tomography, cervical spine; without contrast material |
320 |
290 |
$4K |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
1,923 |
1,710 |
$4K |
| 85379 |
|
1,814 |
1,694 |
$4K |
| 93976 |
|
482 |
438 |
$3K |
| 87077 |
|
1,176 |
1,044 |
$3K |
| 74018 |
|
80 |
72 |
$3K |
| 83605 |
|
3,445 |
2,898 |
$3K |
| 76536 |
|
41 |
40 |
$2K |
| 85610 |
|
1,740 |
1,558 |
$2K |
| 84439 |
|
249 |
239 |
$2K |
| 76642 |
|
42 |
36 |
$1K |
| 71260 |
Computed tomography, thorax, diagnostic; with contrast material |
26 |
26 |
$1K |
| 73560 |
|
39 |
39 |
$995.18 |
| 12011 |
|
14 |
13 |
$968.16 |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
14 |
13 |
$938.15 |
| 73502 |
|
72 |
70 |
$884.64 |
| 97140 |
Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) |
57 |
14 |
$732.85 |
| G0463 |
Hospital outpatient clinic visit for assessment and management of a patient |
23 |
20 |
$732.31 |
| 83880 |
|
1,984 |
1,790 |
$669.31 |
| Q9967 |
Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml |
3,296 |
2,985 |
$665.05 |
| 83690 |
|
5,946 |
5,286 |
$655.82 |
| 82550 |
|
510 |
483 |
$601.56 |
| 77066 |
Tomosynthesis, mammo |
12 |
12 |
$578.26 |
| 12001 |
|
26 |
26 |
$577.43 |
| U0005 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 |
548 |
528 |
$550.00 |
| 86140 |
|
236 |
192 |
$449.01 |
| 83735 |
|
3,088 |
2,656 |
$366.24 |
| 80061 |
Lipid panel |
837 |
808 |
$363.06 |
| G0379 |
Direct admission of patient for hospital observation care |
28 |
27 |
$288.16 |
| 99291 |
Critical care, evaluation and management of the critically ill patient, first 30-74 minutes |
61 |
52 |
$256.27 |
| 97161 |
|
60 |
56 |
$248.63 |
| 84703 |
|
36 |
35 |
$202.75 |
| 82805 |
|
15 |
13 |
$187.31 |
| 83036 |
Hemoglobin; glycosylated (A1C) |
918 |
879 |
$149.04 |
| J1170 |
Injection, hydromorphone, up to 4 mg |
649 |
501 |
$40.56 |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
2,813 |
2,473 |
$39.33 |
| J3010 |
Injection, fentanyl citrate, 0.1 mg |
1,070 |
772 |
$31.10 |
| 84145 |
|
566 |
514 |
$21.28 |
| J2704 |
Injection, propofol, 10 mg |
1,146 |
691 |
$19.69 |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
3,319 |
2,746 |
$11.50 |
| J2250 |
Injection, midazolam hydrochloride, per 1 mg |
712 |
669 |
$9.72 |
| 85730 |
|
429 |
398 |
$8.03 |
| J2270 |
Injection, morphine sulfate, up to 10 mg |
1,178 |
978 |
$7.77 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
1,258 |
1,169 |
$5.46 |
| J0690 |
Injection, cefazolin sodium, 500 mg |
519 |
430 |
$4.62 |
| A9585 |
Injection, gadobutrol, 0.1 ml |
67 |
63 |
$1.96 |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
818 |
698 |
$1.70 |
| J2710 |
Injection, neostigmine methylsulfate, up to 0.5 mg |
68 |
66 |
$0.00 |
| J0665 |
Injection, bupivicaine, not otherwise specified, 0.5 mg |
28 |
25 |
$0.00 |
| J1200 |
Injection, diphenhydramine hcl, up to 50 mg |
389 |
340 |
$0.00 |
| J1171 |
Injection, hydromorphone, 0.1 mg |
61 |
47 |
$0.00 |
| J0780 |
Injection, prochlorperazine, up to 10 mg |
62 |
58 |
$0.00 |
| 87186 |
|
195 |
189 |
$0.00 |
| 90715 |
|
72 |
67 |
$0.00 |
| 82570 |
|
37 |
37 |
$0.00 |
| J2919 |
Injection, methylprednisolone sodium succinate, 5 mg |
82 |
68 |
$0.00 |
| J1644 |
Injection, heparin sodium, per 1000 units |
21 |
12 |
$0.00 |
| J2930 |
Injection, methylprednisolone sodium succinate, up to 125 mg |
47 |
42 |
$0.00 |
| J2550 |
Injection, promethazine hcl, up to 50 mg |
114 |
95 |
$0.00 |
| C9113 |
Injection, pantoprazole sodium, per vial |
14 |
12 |
$0.00 |
| J2272 |
Injection, morphine sulfate (fresenius kabi), not therapeutically equivalent to j2270, up to 10 mg |
19 |
14 |
$0.00 |
| 84100 |
|
17 |
12 |
$0.00 |
| A4216 |
Sterile water, saline and/or dextrose, diluent/flush, 10 ml |
16 |
14 |
$0.00 |
| 29125 |
|
24 |
24 |
$0.00 |
| 82009 |
|
14 |
13 |
$0.00 |
| J2060 |
Injection, lorazepam, 2 mg |
45 |
38 |
$0.00 |
| 86850 |
|
398 |
363 |
$0.00 |
| 85652 |
|
87 |
77 |
$0.00 |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
143 |
127 |
$0.00 |
| A9270 |
Non-covered item or service |
1,221 |
982 |
$0.00 |
| 88304 |
|
123 |
114 |
$0.00 |
| J1940 |
Injection, furosemide, up to 20 mg |
52 |
47 |
$0.00 |
| J7999 |
Compounded drug, not otherwise classified |
20 |
19 |
$0.00 |
| A9579 |
Injection, gadolinium-based magnetic resonance contrast agent, not otherwise specified (nos), per ml |
193 |
183 |
$0.00 |
| 87661 |
Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe |
29 |
26 |
$0.00 |
| J2371 |
Injection, phenylephrine hydrochloride, 20 micrograms |
131 |
115 |
$0.00 |
| J2543 |
Injection, piperacillin sodium/tazobactam sodium, 1 gram/0.125 grams (1.125 grams) |
32 |
27 |
$0.00 |
| 82306 |
Vitamin D; 25 hydroxy, includes fraction(s), if performed |
56 |
53 |
$0.00 |
| J2765 |
Injection, metoclopramide hcl, up to 10 mg |
13 |
12 |
$0.00 |
| 82728 |
|
12 |
12 |
$0.00 |